Develop Business in Global Market, Sido Muncul Open Branch in Philippines and Nigeria

By : Hariyanto And Aldi Firhand. A | Tuesday, April 03 2018 - 21:26 IWST

PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO)
PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO)

INDUSTRY.co.id - Jakarta - PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO) is increasingly aggressively expanding its business in the global market by opening branches in the Philippines and Nigeria.

"We are still exploring to many countries by expanding the marketing area," said Director of PT Jamu and Sido Megah Industries Irwan Hidayat to press in Jakarta, Tuesday (3/4/2018).

Currently, the progress of market expansion to destination countries is still in the process of obtaining permits. "So we are still doing registration at POM (Food Drug Control) in the country there," said Irwan.

He said, in developing the market, Sido Muncul more prioritize the marketing office in many countries, not making factories abroad.

"The business scheme is more efficient and effective for this company. We are looking for distributors there, and for the marketing office, there is no need for the factory there, from Indonesia just send it," said Irwan.

Previously, Finance Director of PT Industri Jamu dan Farmasi Sido Muncul Tbk Venancia Sri Indrijati Wijono said that the export portion of SIDO's revenue is still very small at 1%. However, less than two years, Herbal and Pharmaceutical Industry Sido Muncul targets the export portion can reach 5%.

Given the financial statements of the third quarter-2017, Jamu and Pharmaceutical Industry Sido Muncul recorded net sales of Rp1, 86 trillion. This achievement decreased 1.79% compared to the sales of third quarter-2016 of Rp 1.89 trillion.

The details of the sale of PT Industri Jamu dan Farmasi Sido Muncul Tbk appeared in the third quarter of 2017, for herbal medicine and supplement products amounting to Rp 1.19 trillion or up 7.5% year on year (yoy). Food and beverage products decreased 17.12% to Rp 599.89 billion, while pharmaceutical revenues amounted to Rp 68.53 billion, up 11.55% yoy. (imq)

News Comment

Today's Industry

The President Director of PART, Hamim, talks with the former Agriculture Minister, Anton Apriyantono, and the capital market observer, Yohannis Hans Kwee, at the Nusantara Investment & Opportunities 2025, in Jakarta, Tuesday (11/02/2025)

Selasa, 11 Februari 2025 - 16:31 WIB

Cipta Perdana Lancar Ready to Expand and Diversify for Sustainable Growth

Since its establishment in 2007, PT Cipta Perdana Lancar Tbk (PART) has continued to transform into a major partner in the supply of spare parts for the automotive, sanitary, and electronics…

The Jakarta Convention Center (1001malam.com)

Rabu, 22 Januari 2025 - 12:53 WIB

MICE Activities at JCC Halted, PT GSP Continues Legal Process

PT Graha Sidang Pratama (PT GSP), the investor and manager of the Jakarta Convention Center (JCC), revealed that the company is currently unable to run Meeting, Incentive, Convention and Exhibition…

Images By : Freepik

Sabtu, 14 September 2024 - 16:56 WIB

Essential Tips for Choosing Personal Health Insurance in the US

Choosing the right health insurance plan in the United States can be a complex task, especially with the variety of options available and the ever-changing landscape of healthcare policy. Here…

Images By : Freepik

Sabtu, 14 September 2024 - 16:53 WIB

The Top 10 Insurance Companies in the US for 2024

In the ever-evolving landscape of insurance, selecting the right company can significantly impact your financial security and peace of mind.

Images By : Freepik

Jumat, 13 September 2024 - 15:37 WIB

Why Airbnb Become Popular in 2024?

Airbnb fosters a more interactive experience between hosts and guests. Through direct messaging, guests can inquire about specific details, negotiate pricing, or clarify expectations, which…